Record view
- Product type
- api
- Audit evidence
- No audit report on record.
- Record verified
- 21 August 2026
Official product photograph required — Alchem International, Digoxin Micronised EP/USP
Public Product Record
As published by the manufacturer- Specification
- Cardiac glycoside API, micronised, manufactured against EP/USP monograph.
- Packing
- Not published — quoted against your specification
- MOQ
- Not published — quoted against your specification
- Lead time
- Not published — quoted against your specification
- HS code
- Not published — quoted against your specification
- Price
- Not published — quoted against your specification
Regulatory record — Active Pharmaceutical Ingredient
Verified 21 August 2026- US DMF number
- USDMF-030724Source: alcheminternational.com/pharmaceutical-actives/, accessed 2026-08-21
- US DMF status
- Not published
- CEP status
- CEP 2016-234-Rev 00Source: alcheminternational.com/pharmaceutical-actives/, accessed 2026-08-21
- Letter of Access
- Not published
- LoA turnaround
- Not published
- Last US FDA inspection
- Not published
- Inspection outcome
- Not published
- Pharmacopoeia
- EP, USPSource: alcheminternational.com/pharmaceutical-actives/, accessed 2026-08-21
- Capacity available now
- Not published
- US supply active
- Not published
- Backward integrated
- Not published
- Multi-site
- Not published
Audit evidence
Licensed in from the accredited body named — never an Indiasay auditNo audit report on record.
Documentation available
Released against a named consignee- ·Certificate of analysis for the supplied lot
- ·Specification sheet, countersigned
- ·Packing list and lot coding
- ·Origin declaration
- ·Destination-market documentation per the category guide
Released against a named consignee. Held by the manufacturer, transmitted by Indiasay.